series-c-plus
Stage
2
Investors
About
Harbour Antibodies develops antibody-based therapeutics and related antibody technologies for pharmaceutical and biotechnology companies.
Explore Harbour Antibodies's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.